Skip to content

Jai Whelan

Department of Psychology, University of Otago, William James Building, Level 1, 275 Leith Walk, Ōtepoti/Dunedin, Aotearoa, 9016, New Zealand. jai.whelan@postgrad.otago.ac.nz.

3 papers in the library · 11 citations · publishing 2024-2025

Papers

Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand.

Harm reduction journal March 21, 2024 Jai Whelan, Geoff Noller, Ryan D Ward 6 citations

MDMA is widely used in Aotearoa New Zealand and is the main drug analyzed by legal drug checking services. An online survey of 915 people who use MDMA (60.7% female, ages 18-65, median 24) found that most carried out harm reduction behaviors relatively frequently, but those who reported experiencing harm from MDMA or a substance mistaken for MDMA engaged in these behaviors less often. Reagent testing was used by 42.3% of the sample, and 27% had used KnowYourStuffNZ services, with 95.9% of clients learning about harm reduction and 53.3% changing their behavior. Harm was reported by 14.4% of the sample, primarily physical or psychological, and potential MDMA dependence was apparent in 6.9%. The findings emphasize the need for greater availability of drug checking services.

Exploring Motivations, Experiences, and Consequences of Psychedelic Use in Aotearoa New Zealand.

Journal of psychoactive drugs March 5, 2025 Ethan Mills, Jai Whelan, Sarah Mcgruddy et al. 3 citations

An online survey of 997 people in Aotearoa New Zealand who had used a classical psychedelic found that worst experiences differed substantially from best experiences across emotional, cognitive, and relational domains, while typical experiences more closely resembled best experiences. Motivations for use changed after the initial experience, and motivations associated with different experience types varied. A higher number of psychedelic use occasions, along with therapeutic and growth-oriented motivations, were significant predictors of positive psychological health impact. Consequences of psychedelic use were mostly positive, with best experiences resulting in the most benefit. The findings highlight the potential of psychedelic experiences for personal growth and wellbeing.

A thematic analysis of MDMA-related harm and harm reduction experiences and knowledge in Aotearoa New Zealand.

Harm reduction journal May 23, 2024 Jai Whelan, Ryan D Ward, Geoff Noller 2 citations

MDMA is less harmful than many other drugs but still causes significant harms, including deaths. Sixty people who use MDMA in southern Aotearoa New Zealand, aged 18 to 67 (median 21), shared their views on harm and harm reduction in 14 focus groups. Five themes emerged: mindset and setting matter; looking after your body and mind and not overdoing it; other substances increase risk and harm; trusted friends and peers are protective; and valid information is key for healthy self-determination, with a subtheme that drug checking is essential harm reduction. These findings aim to inform national drug policy and improve harm reduction practices for consumers and organisations.